Can-Fite BioPharma Ltd. CANF
1.62 USD -0.01 (-0.31%)
Nov 4, 2026, 10:03 AM EST
1.62 Day range 1.64
1.60 52-week range 12.40
- YTD
- -59.62%
- 1 year
- -80.30%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 14.00 +766.9% upside
Now 1.62
- Target (low)
- 10.00
- Target (mean)
- 14.00
- Target (high)
- 18.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 150.00K | -23.5% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 150.00K | -23.5% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 500.00K | -32.7% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 20.00M | +3900.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 17, 2024 | EF Hutton | Initiated | — | Buy |
| May 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 24, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 2, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 13, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |